Ginkgo Bioworks Holdings (DNABW) Depreciation & Amortization (CF) (2020 - 2026)

Ginkgo Bioworks Holdings has reported Depreciation & Amortization (CF) for 7 years, with the latest figure at $12.8 million in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 13.65% year-over-year to $12.8 million; the trailing twelve-month figure through Mar 2026 stood at $56.4 million (down 13.16% YoY), and the FY2025 full-year result was $59.0 million, down 6.39% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $12.8 million, down from $13.7 million in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $21.1 million in Q3 2023, with the low at $8.9 million in Q3 2022.
• Historically, Depreciation & Amortization (CF) has averaged $14.5 million across 5 years, with a median of $14.8 million in 2025.
• Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) surged 136.18% — and 2024, when it tumbled 32.12%.
• Ginkgo Bioworks Holdings' Depreciation & Amortization (CF) stood at $15.7 million in 2022, then declined by 18.06% to $12.8 million in 2023, then climbed by 21.93% to $15.7 million in 2024, then retreated by 12.71% to $13.7 million in 2025, then retreated by 6.32% to $12.8 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $12.8 million (Q1 2026), $13.7 million (Q4 2025), and $14.2 million (Q3 2025), per Business Quant data.